Dr. Fortune is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
665 Huntington Ave
Boston, MA 02115Phone+1 617-432-3337
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2000 - 2005
Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 2000
Columbia University Vagelos College of Physicians and SurgeonsClass of 1996
Certifications & Licensure
MA State Medical License 1999 - 2026
Publications & Presentations
PubMed
- Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal models.Xin Wang, Hongwei Su, Joshua B Wallach, Jeffrey C Wagner, Benjamin J Braunecker
Nature Microbiology. 2025-01-10 - High-dose intravenous BCG vaccination induces enhanced immune signaling in the airways.Joshua M Peters, Edward B Irvine, Mohau S Makatsa, Jacob M Rosenberg, Marc H Wadsworth 2nd
Science Advances. 2025-01-03 - 1 citationsHumoral correlates of protection againstfollowing intravenous BCG vaccination in rhesus macaques.Edward B Irvine, Patricia A Darrah, Shu Wang, Chuangqi Wang, Ryan P McNamara
Iscience. 2024-12-20
Journal Articles
- Concurrent Infection with Mycobacterium Tuberculosis Confers Robust Protection Against Secondary Infection in MacaquesSarah M Fortune, Philana Ling Lin, PLoS One
- Immunological Mechanisms of Human Resistance to Persistent Mycobacterium Tuberculosis InfectionRobert S Wallis, W Henry Boom, Thomas R Hawn, Sarah Fortune, Nature
- Small RNA Profiling in Mycobacterium Tuberculosis Identifies MrsI as Necessary for an Anticipatory Iron Sparing ResponseSarah Fortune, MD, Proceedings of the National Academy of Sciences
Press Mentions
Immune Protection Against Tuberculosis Reinfection Driven by Cells That Dampen Lung InflammationAugust 29th, 2024- Repeat Vaccinations and Immune Exhaustion: A Possible but Unlikely LinkDecember 3rd, 2022
- Can You Be ‘Too Boosted’ with COVID-19 Vaccines?April 5th, 2022
- Join now to see all
Grant Support
- Variation In M. Tuberculosis In Response To Host SelectionOffice Of The Director, National Institutes Of Health2007–2009
- PE And PPE FunctionNational Institute Of Allergy And Infectious Diseases2007–2008
- M Tuberculosis Evasion Of The Innate Immune ResponseNational Institute Of Allergy And Infectious Diseases2002–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
